Institute of Biomedical Research Corp. logo

Institute of Biomedical Research Corp. (MRES)

Market Closed
12 Dec, 20:00
OTC PINK OTC PINK
$
0. 01
+0
+10.09%
$
45.34M Market Cap
- P/E Ratio
0% Div Yield
555,843 Volume
0 Eps
$ 0.01
Previous Close
Day Range
0 0.01
Year Range
0 0.03
Want to track MRES and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MRES closed Friday higher at $0.01, an increase of 10.09% from Thursday's close, completing a monthly increase of 9.09% or $0. Over the past 12 months, MRES stock gained 5,900%.
MRES is not paying dividends to its shareholders.
The last earnings report, released on Jun 30, 2015, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Institute of Biomedical Research Corp. has completed 1 stock splits, with the recent split occurring on Apr 28, 2014.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

MRES Chart

MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences

MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences

DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing health and wellness through innovative science-driven solutions. Specialising in researching, developing, and commercialising cutting-edge products in nutrition, health, and sustainability.

Accesswire | 1 year ago
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers

MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers

CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions, is pleased to announce the following updates with its M2Bio Food and Beverage division: M2Bio Food and Beverage, known for its premium, healthy, and sustainably sourced products, is taking a significant step forward by announcing a strategic shift in its product lineup. After several successful years of exploring CBD-infused food products, the company has decided to discontinue this line and refocus efforts on expanding its core offerings.

Accesswire | 1 year ago

Institute of Biomedical Research Corp. (MRES) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Institute of Biomedical Research Corp. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is MRES.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 45.34M.

Has Institute of Biomedical Research Corp. ever had a stock split?

Institute of Biomedical Research Corp. had 1 splits and the recent split was on Apr 28, 2014.

Institute of Biomedical Research Corp. Profile

Biotechnology Industry
Healthcare Sector
Dr. Drasko D. Pekovic CEO
OTC PINK Exchange
US45781A1079 ISIN
ME Country
- Employees
- Last Dividend
28 Apr 2014 Last Split
- IPO Date

Overview

The Institute of Biomedical Research Corp., established in 2010, is at the forefront of delivering cutting-edge biomedical research and analytical services both locally in Montenegro and on a global scale. It specializes in a broad range of areas including the regulatory control of industrial activities and products, scientific monitoring of the living environment, and the development of new diagnostic methods and experimental medical treatments. The company not only focuses on the research and development of biomedical products and technologies but also on their regulatory evaluation and certification. Additionally, its efforts extend to fundamental scientific research and the advancement of knowledge in the biomedical and environmental fields. With a commitment to quality and innovation, the Institute of Biomedical Research Corp. operates from its headquarters in Podgorica, Montenegro, and maintains a representative office in Montreal, Canada, facilitating its international outreach and collaboration.

Products and Services

  • Graduate Research Studies Programs - Offering advanced programs for graduate students in biomedical and environmental fields, fostering the next generation of scientists and researchers.
  • Healthcare Devices - The company provides an array of healthcare devices including two channel analog NMS, digital muscle stimulators, digital TENS, interferential devices, elite combination devices, portable four channel digital devices, and portable ultrasound devices. These are aimed at enhancing patient care and treatment outcomes.
  • Photon Red Light and Electric Pain Relief Products - Specialized products for beauty treatments and pain relief, including microcurrent electrical nerve stimulators and high volt pulsed stimulators, focusing on non-invasive treatment options.
  • Microbicidal Agents and Disinfectant Products - Researching and developing microbicidal agents suitable for a wide range of applications from large burns bandages to hard surface disinfection, offering solutions for infection control and hygiene.
  • Purilair - An innovative appliance designed to sterilize compressed air circulating within medical instruments, enhancing the safety and efficacy of medical treatments.
  • Colloidal Silver and Electromedical Devices - The company is involved in the development and commercialization of colloidal silver products and electromedical devices for various medical applications.
  • BioStim INF - A device used for edema reduction, pain relief, and total treatment, representing the company’s commitment to non-invasive therapeutic technologies.
  • Quality Control, Regulatory, and Environmental Services - Offering a comprehensive suite of services including quality control, regulatory certifications for new biomedical products, environmental analysis, building decontamination, and environmental protection and management services. These services ensure the safety, efficacy, and regulatory compliance of products and operations.

Contact Information

Address: Ljubljanska bb
Phone: 382 20 663 075